News Daily News Stent Thrombosis Risk Lower with Xience vs. First-Generation DES Yael L. Maxwell March 06, 2012
News Daily News Meta-Analysis: Mixed Results Seen with First-Gen DES in STEMI Patients March 05, 2012
News Industry News Boston Scientific Receives Industry's First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients February 21, 2012
News Daily News Complications of In-Stent Restenosis High, Traditional Risk Factors Absent Yael L. Maxwell February 15, 2012
Presentation A Multicenter Randomized Trial Comparing Amphilimus- With Paclitaxel-Eluting Stents in De Novo Native Coronary Artery Lesions Presenter: Didier Carrie January 24, 2012
Presentation TCT 2012 Use Of Paclitaxel-Eluting Stents Reduces Target Lesion Revascularization for Dialysis Patients. Presenter: Hirotoshi Watanabe, Kyohei Yamaji, Yoshimitsu Soga, Shinichi Shirai, Kenji Ando, Koyu Sakai, Katsuhiro Kondo, Masashi Iwabuchi, Hiroyoshi Yokoi, Hideyuki Nosaka, Masakiyo Nobuyoshi January 03, 2012
Presentation TCT 2012 Two-Year Outcomes of a Propensity-Matched Comparison of the ION and TAXUS Liberté Paclitaxel-Eluting Stents. Presenter: Dean J. Kereiakes, Louis A. Cannon, John A. Ormiston, Hong Wang, Paul L. Underwood, Keith D. Dawkins January 03, 2012
Presentation TCT 2012 No Difference In Long-term Major Adverse Cardiac Event Rates Between Paclitaxel-eluting and Sirolimus-eluting Stents. Presenter: James P. Howard, Zia Buckhoree, Dan A. Jones, Sean M. Gallagher, Krishnaraj S. Rathod, Ajay K. Jain, Charles Knight, Anthony Mathur, Andrew Wragg January 03, 2012
Presentation TCT 2012 Long-term outcome after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a... Presenter: Petri O. Tuomainen, Antti Ylitalo, Matti Niemel?, Mikko Pietil?, Jussi Sia, Kai Nyman, Juhani Airaksinen, Pasi P. Karjalainen January 03, 2012
Presentation TCT 2012 Impact of Stent Platform of Paclitaxel-eluting Stents: Detailed Assessment of Neointimal Distribution by Optical Coherence Tomography Presenter: Hiromasa Otake, Toshiro Shinke, Junya Shite, Masayuki Nakagawa, Ryoji Nagoshi, Tsuyoshi Osue, Ken-ichi Hirata January 03, 2012
Presentation TCT 2012 Impact of Peristent Plaque Change after Drug-Eluting Stents Implantation -Comparison between Zotarolimus-Eluting Stents and Paclitaxel-Eluting Stents- Presenter: Yoshitaka Muraoka, Shinjo Sonoda, Kuninobu Kashiyama, Reo Anai, Fumihiko Kamezaki, Yuki Tsuda, Masaru Araki, Masahiro Okazaki, Yutaka Otsuji January 03, 2012
Presentation TCT 2012 Elevated Pre-procedural High-sensitive CRP Levels are Associated with Uneven Vessel Healing after Paclitaxel-eluting Stents Implantation in Patients with Stable Angina Presenter: Hiromasa Otake, Junya Shite, Toshiro Shinke, Ken-ichi Hirata January 03, 2012
Presentation TCT 2012 Comparison by Optical Frequency-Domain Imaging of Paclitaxel-Eluting Stents and Everolimus-Eluting Stents Implanted in One Coronary Artery in One Procedure. A 12 Months Follow... Presenter: Jose M. De la Torre Hernandez, Dae-Hyun Lee, Tamara Garcia Camarero, Piedad Lerena, Gonzalo Martin Gorria, Fermin Sainz Laso, Javier Zueco January 03, 2012
News Conference News ROTAXUS: Rotablation Does Not Improve Stenting Results in Calcified Lesions Yael L. Maxwell November 30, 2011
News Conference News PEPCAD-DES: Drug-Coated Balloon Better Than Uncoated Balloon for DES Restenosis November 27, 2011